
河南普瑞制药有限公司
河南普瑞制药有限公司
About Us
Contact Supplier
(2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid
Chemicals/Carbon Materials/GraphiteNegotiable
Send Inquiry
1,3,5-Trimethoxybenzene
Chemicals/Other Organic Raw Materials/Aromatic CompoundsNegotiable
Send Inquiry
sucrose octasulfate - aluminum complex
Beauty & Personal Care/API & Bulk DrugsNegotiable
Send Inquiry
Aminomethylbenzoic acid
Chemicals/Fine Chemical Intermediates/Benzene Series IntermediatesNegotiable
Send Inquiry
Neostigmine methyl sulfate
Chemicals/Pharmaceutical & Biochemical/APIs (Active Pharmaceutical Ingredients)Negotiable
Send Inquiry
Urapidil hydrochloride
Chemicals/Pharmaceutical & Biochemical/APIs (Active Pharmaceutical Ingredients)Negotiable
Send Inquiry
Dobutamine HCL
Chemicals/Pharmaceutical & Biochemical/APIs (Active Pharmaceutical Ingredients)Negotiable
Send Inquiry
Ethyl 4-hydroxy-2-methyl-1,1-dioxo-2H-1,2-benzothiazine-3-carboxylate
Chemicals/Carboxylic Acid Derivatives/EstersNegotiable
Send Inquiry
Henan Purui Pharmaceutical Co., Ltd., located in Xihua County, Henan Province, covers an area of over 20,000 square meters. It is a specialized manufacturer of anticholinergic active pharmaceutical ingredients (APIs) in China and an important export base, certified by the National GMP (Good Manufacturing Practice) standards.
The company currently employs over 300 staff, including 72 professional and technical personnel (with intermediate and senior professional titles), and has fixed assets worth 40 million RMB. With strong technical capabilities, advanced production processes, and comprehensive testing instruments, the company strictly adheres to the "Good Manufacturing Practice for Pharmaceutical Products" in organizing production. It has established long-term cooperative relationships with the School of Pharmacy of Zhengzhou University and the Zhengzhou University New Drug R&D Center. On November 1, 2009, the company successfully passed the GMP inspection by the National Medical Products Administration (certificate numbers KO105 and G0037). It specializes in the production of APIs such as Racemic Anisodamine (National Drug Approval Number H19983090), Atropine Sulfate (National Drug Approval Number H20073819), Levofloxacin Hydrochloride, as well as various pharmaceutical intermediates including Tropine and Tropinol.
The company adheres to the management principle of "Quality First, People-Oriented," embraces a corporate spirit of keeping pace with the times and forging ahead with determination, and builds the image of Purui Pharmaceutical professionals with integrity.